Athena Gold Corporation: Athena Gold Closes CDN $500,000 First Tranche of Private Placement and Applies for Listing on the Canadian Stock Exchange
VACAVILLE, CA / ACCESSWIRE / June 9, 2021 / Athena Gold Corporation (OTCQB:AHNR) (
Athena or the
Company ) is pleased to announce that the Company has closed the first tranche of a non-brokered private placement offering (the
Offering ) of units of the Company (each, a
Unit ) at a price of CDN $0.08 per Unit. Each Unit consists of one common share in the capital stock of the Company and one common share purchase warrant, with each warrant entitling the holder thereof to purchase one common share in the capital stock of the Company at a price of CDN $0.15 until May 31, 2024.
First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds plc ISIN
Quarterly
Quarterly
Quarterly
UCITS ETF Class B
Quarterly
UCITS ETF Class B
The Funds are advised by First Trust Advisors L.P. ( FTA ).
The following dates apply to today s distribution declaration:
Expected Ex-Dividend Date:
About First Trust Advisors L.P.
FTA is a privately owned US-based financial services firm and is registered as an investment adviser with the United States Securities and Exchange Commission. FTA acts as adviser to a range of Irish domiciled UCITS funds under the First Trust Global Funds plc umbrella. The Funds distributors are FTGPM and First Trust Global Portfolios Limited ( FT UK ), an affiliate of FTA. FTGPM is the management company of First Trust Global Funds plc umbrella. FT UK was established in December 2011 as a UK-based and UK Financial Conduct Authority ( FCA ) regulated distributor and advisor
L Squared Capital Partners Announces Pending Sale of Kanopy to OverDrive streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Vuzix Smart Glasses Expand AR Surgical Product Presence to Support Shoulder, Knee and Spine Surgeries
- NextAR surgical AR platform developed by Medacta International receives CE marking for knee, shoulder and spine applications.
- NextAR surgical AR platform receives US Food and Drug Administration (FDA) clearance for shoulder application.
News provided by
Share this article
Share this article
ROCHESTER, N.Y., June 9, 2021 /PRNewswire/ Vuzix® Corporation (NASDAQ: VUZI), ( Vuzix or, the Company ), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced the market expansion to support the NextAR surgical AR platform developed by Medacta International, one of the world s largest providers of innovative orthopedic products focusing on healthcare sustainability. Having used the Vuzix Blade to complete the first smart glasses-based total knee replacement in the US in 2020, Medacta recently received its CE marking for knee, sho